Clinical Trial Update: Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease

View source ↗

Summary

Completed clinical trial evaluating long-haul COVID-19 and vaccine immunogenicity in patients with liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Liver Failure
• Liver Transplant Recipients
• Portal Hypertension

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: COVID-19, Chronic Liver Failure | Status: COMPLETED